journal article·2023-04-11Open access

Proteinoid Polymers and Nanocapsules for Cancer Diagnostics, Therapy and Theranostics: In Vitro and In Vivo Studies

Ella Itzhaki, Yuval Elias, Neta Moskovits, Salomon M. Stemmer, Shlomo Margel

Abstract

Proteinoids—simple polymers composed of amino acids—were suggested decades ago by Fox and coworkers to form spontaneously by heat. These special polymers may self-assemble in micrometer structures called proteinoid microspheres, presented as the protocells of life on earth. Interest in proteinoids increased in recent years, in particular for nano-biomedicine. They were produced by stepwise polymerization of 3–4 amino acids. Proteinoids based on the RGD motif were prepared for targeting tumors. Nanocapsules form by heating proteinoids in an aqueous solution and slowly cooling to room temperature. Proteinoid polymers and nanocapsules suit many biomedical applications owing to their non-toxicity, biocompatibility and immune safety. Drugs and/or imaging reagents for cancer diagnostic, therapeutic and theranostic applications were encapsulated by dissolving them in aqueous proteinoid solutions. Here, recent in vitro and in vivo studies are reviewed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Monoclonal and Polyclonal Antibodies Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan 5290002, Israel

Felsenstein Medical Research Center, Petah Tikva 49100, Israel

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel

References (64)

Show source-provided references
1. From proteinoid microsphere to contemporary cell: Formation of internucleotide and peptide bonds by proteinoid particles10.1007/BF00927027 ↗
2. Selective action in boundaries of particles of thermal proteinoid
3. The proteinoid theory of the origin of life and competing ideas10.2307/4444705 ↗
4. The thermal condensation of glutamic acid and glycine to linear peptides10.1021/ja01544a027 ↗
5. Electrical excitability of proteinoid microspheres composed of basic and acidic proteinoids10.1016/0303-2647(84)90011-X ↗
6. Excitable cell made of thermal proteinoids10.1016/0303-2647(85)90044-9 ↗
7. Synthesis and aggregational behavior of acidic proteinoid10.1002/(SICI)1099-0518(199610)34:14<2915::AID-POLA8>3.0.CO;2-P ↗
8. Preparation and characterization of pH-sensitive proteinoid microspheres for the oral delivery of methotrexate10.1016/S0142-9612(97)00188-9 ↗
9. Targeted delivery of CBD-loaded poly(RGD) proteinoid nanoparticles for antitumor therapy
10. Engineered doxorubicin delivery system using proteinoid-poly(L-lactic acid) polymeric nanoparticles of narrow size distribution and high molecular weight for cancer treatment
11. Recent advances of novel proteinoids and proteinoid nanoparticles and their applications in biomedicine and industrial uses10.1002/ijch.201800021 ↗
12. Hadad, E., Rudnick-Glick, S., Ithaki, E., Avivi, M.Y., Grinberg, I., Elias, Y., and Margel, S. (2020). Engineering of doxorubicin-encapsulating and TRAIL-conjugated poly(RGD) proteinoid nanocapsules for drug delivery applications. Polymers, 12.10.3390/polym12122996 ↗
13. Synthesis and characterization of Poly(RGD) proteinoid polymers and NIR fluorescent nanoparticles of optimal D, L-configuration for drug-delivery applications— in vitro study10.1021/acsomega.0c01916 ↗
14. Engineering of near infrared fluorescent proteinoid-poly(L-lactic acid) particles for in vivo colon cancer detection10.1186/s12951-014-0030-z ↗
15. Disulfide proteinoid micelles responsive to reduction10.1080/01932691.2018.1515026 ↗
16. Towards proteinoid computers. hypothesis paper10.1016/j.biosystems.2021.104480 ↗
17. Sharma, S., Mougoyannis, P., Tarabella, G., and Adamatzky, A. (2022). A review on the protocols for the synthesis of proteinoids. arXiv.
18. Thermal copolymerization of amino acids in the presence of phosphoric acid10.1016/0003-9861(60)90419-7 ↗
19. Itzhaki, E., Hadad, E., Moskovits, N., Stemmer, S.M., and Margel, S. (2021). Tumor-targeted fluorescent proteinoid nanocapsules encapsulating synergistic drugs for personalized cancer therapy. Pharmaceuticals, 6.10.3390/ph14070648 ↗
20. Tailor made magnetic nanolights: Fabrication to cancer theranostics applications10.1039/D1NA00447F ↗
21. Optimizing the image of fluorescence cholangiography using ICG: A systematic review and ex vivo experiments10.1007/s00464-018-6233-x ↗
22. NIR-II fluorescence imaging using indocyanine green nanoparticles10.1038/s41598-018-32754-y ↗
23. Tumor-specific labeling of pancreatic cancer using a humanized anti-CEA antibody conjugated to a near-infrared fluorophore10.1245/s10434-018-6344-6 ↗
24. Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization10.1016/j.ijpharm.2020.120117 ↗
25. Neun, B.W., Barenholz, Y., Szebeni, J., and Dobrovolskaia, M.A. (2018). Understanding the role of anti-PEG antibodies in the complement activation by Doxil in vitro. Molecules, 23.10.3390/molecules23071700 ↗
26. Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs10.1016/j.jconrel.2019.06.007 ↗
27. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the Molecule10.1038/309030a0 ↗
28. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature10.1016/j.drup.2005.10.002 ↗
29. RGD and other recognition sequences for integrins10.1146/annurev.cellbio.12.1.697 ↗
30. New perspectives in cell adhesion: RGD and integrins10.1126/science.2821619 ↗
31. RGD Peptide as a targeting moiety for theranostic purpose: An update study10.1007/s10989-018-9728-3 ↗
32. Structural studies of two antiaggregant RGDW peptides by 1H and 13C NMR10.1111/j.1399-3011.1994.tb00406.x ↗
33. Intraoperative identification of liver cancer microfoci using a targeted near-infrared fluorescent probe for imaging-guided surgery10.1038/srep21959 ↗
34. In vivo biodistribution of engineered lipid microbubbles in rodents10.1021/acsomega.9b01544 ↗
35. Multi-modal Mn–Zn ferrite nanocrystals for magnetically-induced cancer targeted hyperthermia: A comparison of passive and active targeting effects10.1039/C6NR03916B ↗
36. Engineering of NIR fluorescent PEGylated poly(RGD) proteinoid polymers and nanoparticles for drug delivery applications in chicken embryo and mouse models10.1039/D0RA06069K ↗
37. Opportunities for organocatalysis in polymer synthesis via step-growth methods10.1016/j.progpolymsci.2018.11.003 ↗
38. Self-assembled levan nanoparticles for targeted breast cancer imaging10.1039/C4CC07679F ↗
39. Evaluation of temperature-sensitive, indocyanine green-encapsulating micelles for noninvasive near-infrared tumor imaging10.1007/s11095-010-0190-y ↗
40. Consensus guidelines for the use and interpretation of angiogenesis assays
41. The role of integrins in inflammation and angiogenesis
42. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting10.1016/j.biomaterials.2014.02.031 ↗
43. One-step synthesis of linear and cyclic RGD conjugated gold nanoparticles for tumour targeting and imaging10.1039/c3ra47729k ↗
44. Effect of polydeoxyribonucleotide on angiogenesis and wound healing in an in vitro model of osteoarthritis10.1177/0963689718804130 ↗
45. Block copolymer micelles as vehicles for drug delivery10.1016/0168-3659(93)90172-2 ↗
46. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy10.1016/j.addr.2009.03.009 ↗
47. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography10.1016/j.biomaterials.2011.10.052 ↗
48. Dye-loaded nanoemulsions: Biomimetic fluorescent nanocarriers for bioimaging and nanomedicine10.1002/adhm.202001289 ↗
49. The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation10.3390/polym12020298 ↗
50. Quantitative imaging of lymphatic function with liposomal indocyanine green10.1158/0008-5472.CAN-10-0271 ↗
51. Chick embryo chorioallantoic membrane (CAM): An alternative predictive model in acute toxicological studies for anti-cancer drugs10.1538/expanim.14-0059 ↗
52. Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors10.1016/j.biomaterials.2013.12.086 ↗
53. Cellular interactions of liposomes and PISA nanoparticles during human blood flow in a microvascular network10.1002/smll.202002861 ↗
54. Influence of nanoparticle shapes on cellular uptake of paclitaxel loaded nanoparticles in 2D and 3D cancer models10.1039/C7PY00385D ↗
55. In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy10.1016/j.ijpharm.2015.04.054 ↗
56. TRAIL and cancer therapy10.1016/j.canlet.2008.02.003 ↗
57. Itzhaki, E., Chausky-Barzakh, E., Atkins, A., Bareket-Samish, A., Stemmer, S.M., Moskovits, N., and Margel, S. (2023). Tumor-targeted poly(ArgGlyAsp) nanocapsules for personalized cancer therapy-In vivo study. Adv. Ther., 1–34.10.1002/adtp.202200337 ↗
58. Administration of substances to laboratory animals: Routes of administration and factors to consider
59. Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: A review
60. Palbociclib-induced pneumonitis: A case report and review of the literature
61. (2019). Alpelisib Palbociclib HPLC Report, Faculty of Life Sciences, Bar-Ilan University.
62. AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer10.1038/s41467-022-31668-8 ↗
63. Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment10.1038/s41467-020-17996-7 ↗
64. Palbociclib in combination with sunitinib exerts a synergistic anti-cancer effect in patient-derived xenograft models of various human cancers types10.1016/j.canlet.2022.215665 ↗